$CLVS Company News Six stocks to watch 12:47 p
Post# of 44842
Posted On: 01/14/2015 10:26:05 AM
$CLVS Company News
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
Clovis falls 22% over two days on disappointing cancer drug trials 10:56 a.m. June 3, 2014 - Russ Britt
Clovis shares jump as company prepares to give cancer drug results 1:31 p.m. May 15, 2014 - Russ Britt
Biotechs, bonds and more from the 'tempest in a microsecond' 7:32 a.m. April 2, 2014 - Shawn Langlois
Charting a firmly-grounded, bull-market trend 1:01 p.m. March 4, 2014 - Michael Ashbaugh
Charting a firmly-grounded, bull-market trend 12:41 p.m. March 4, 2014 - Michael Ashbaugh
Losses widen, but investors heartened by Clovis drug results 11:01 a.m. Feb. 28, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
Trade what you see, not what you believe 12:30 p.m. Aug. 29, 2013 - The Trading Deck
There are two ways to play earnings 11:00 a.m. Aug. 1, 2013 - The Trading Deck
5 stocks that hedge funds are buying 11:35 a.m. June 24, 2013 - Insider Monkey
Clovis Oncology unveils $170 mln share offering 7:09 a.m. June 10, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:53 p.m. Nov. 12, 2012 - Wallace Witkowski
Clavis plunges after negative cancer drug trial 8:40 a.m. Nov. 12, 2012 - MarketWatch.com
IPO scorecard: Update on selected offering 1:18 p.m. June 8, 2012 - Dow Jones
Stocks to watch Wednesday: DDi, SanDisk, Mitcham 7:26 a.m. April 4, 2012 - MarketWatch
InvenSense closes up 19% after IPO; Clovis down 4:45 p.m. Nov. 16, 2011 - MarketWatch.com
Biopharma Clovis trades higher post-IPO 12:18 p.m. Nov. 16, 2011 - MarketWatch.com
Clovis Oncology, Inc. (CLVS) in Focus: Stock Jumps 5.9% - Tale of the Tape 9:18 a.m. Today - Zacks.com
Hottest Healthcare Stocks Now – ARIA ACHN KERX CLVS 12:15 p.m. Jan. 7, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – SGMO ANAC CMN CLVS 6:00 a.m. Dec. 31, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
FDA Approves AstraZeneca Ovarian Cancer Drug 5:12 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog 4:48 p.m. Dec. 19, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – PODD INCY ACAD ALNY 12:15 p.m. Dec. 17, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ZLTQ PBYI CLVS ACHC 12:30 p.m. Dec. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISRG VRTX CLVS VAR 1:45 p.m. Dec. 8, 2014 - InvestorPlace.com
Vargatef cleared in Europe for lung cancer 9:23 a.m. Nov. 28, 2014 - Seeking Alpha
CO-1686 Data Confirmed Efficacy, Take Advantage Of Weakness In Clovis Oncology Shares Ahead Of Rucaparib Outcomes Data 11:41 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly 9:38 a.m. Nov. 19, 2014 - TheStreet.com
Clovis off premarket after report on CO-1686 9:21 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis teams up with Glaxo on combo cancer therapy 7:20 a.m. Nov. 18, 2014 - Seeking Alpha
Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline 4:00 p.m. Nov. 17, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Presents at Credit Suisse 2014 Healthcare Conference (Transcript) 9:10 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: CLOVIS ONCOLOGY, INC. 1:13 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS 7:33 a.m. Nov. 7, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q3 2014 Results - Earnings Call Transcript 9:40 p.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings after Thursday’s close 5:35 p.m. Nov. 5, 2014 - Seeking Alpha
Clovis Oncology to Present at the 33rd Annual J.P. Morgan Healthcare Conference 6:30 p.m. Jan. 5, 2015 - BusinessWire - BZX
Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib 6:05 p.m. Nov. 19, 2014 - BusinessWire - BZX
Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline 5:00 p.m. Nov. 17, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in TIGER-1 Study 5:28 p.m. Nov. 12, 2014 - BusinessWire - BZX
Clovis Oncology Announces Third Quarter 2014 Operating Results 4:05 p.m. Nov. 6, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Credit Suisse Healthcare Conference 4:11 p.m. Nov. 4, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer 3:52 p.m. Oct. 23, 2014 - BusinessWire - BZX
Clovis Oncology to Announce Third Quarter 2014 Financial Results and Host Webcast Conference Call on November 6 8:03 a.m. Oct. 22, 2014 - BusinessWire - BZX
Critical Alerts For Yahoo!, Clovis Oncology, Sears Holdings, PetSmart and Endo Health Solutions Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in FGF-aberrant Advanced Breast Cancer 3:01 p.m. Sept. 10, 2014 - BusinessWire - BZX
Clovis Oncology Announces Exercise in Full by Initial Purchasers of Their Option to Purchase an Additional $37.5 Million Aggregate Principal Amount of the Company’s 2.50% Convertible Senior Notes Due 2021 7:02 a.m. Sept. 9, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference 5:01 a.m. Sept. 8, 2014 - BusinessWire - BZX
Clovis Oncology Announces Pricing of $250 Million of Convertible Senior Notes 7:22 p.m. Sept. 3, 2014 - BusinessWire - BZX
Clovis Oncology to Offer $200 Million of Convertible Senior Notes 3:03 p.m. Sept. 2, 2014 - BusinessWire - BZX
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
Clovis Oncology Announces Second Quarter 2014 Operating Results 3:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 7:10 a.m. July 17, 2014 - PR Newswire - PRF
Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon 4:10 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 6:50 a.m. June 27, 2014 - PR Newswire - PRF
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
Clovis falls 22% over two days on disappointing cancer drug trials 10:56 a.m. June 3, 2014 - Russ Britt
Clovis shares jump as company prepares to give cancer drug results 1:31 p.m. May 15, 2014 - Russ Britt
Biotechs, bonds and more from the 'tempest in a microsecond' 7:32 a.m. April 2, 2014 - Shawn Langlois
Charting a firmly-grounded, bull-market trend 1:01 p.m. March 4, 2014 - Michael Ashbaugh
Charting a firmly-grounded, bull-market trend 12:41 p.m. March 4, 2014 - Michael Ashbaugh
Losses widen, but investors heartened by Clovis drug results 11:01 a.m. Feb. 28, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
Trade what you see, not what you believe 12:30 p.m. Aug. 29, 2013 - The Trading Deck
There are two ways to play earnings 11:00 a.m. Aug. 1, 2013 - The Trading Deck
5 stocks that hedge funds are buying 11:35 a.m. June 24, 2013 - Insider Monkey
Clovis Oncology unveils $170 mln share offering 7:09 a.m. June 10, 2013 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:53 p.m. Nov. 12, 2012 - Wallace Witkowski
Clavis plunges after negative cancer drug trial 8:40 a.m. Nov. 12, 2012 - MarketWatch.com
IPO scorecard: Update on selected offering 1:18 p.m. June 8, 2012 - Dow Jones
Stocks to watch Wednesday: DDi, SanDisk, Mitcham 7:26 a.m. April 4, 2012 - MarketWatch
InvenSense closes up 19% after IPO; Clovis down 4:45 p.m. Nov. 16, 2011 - MarketWatch.com
Biopharma Clovis trades higher post-IPO 12:18 p.m. Nov. 16, 2011 - MarketWatch.com
Clovis Oncology, Inc. (CLVS) in Focus: Stock Jumps 5.9% - Tale of the Tape 9:18 a.m. Today - Zacks.com
Hottest Healthcare Stocks Now – ARIA ACHN KERX CLVS 12:15 p.m. Jan. 7, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – SGMO ANAC CMN CLVS 6:00 a.m. Dec. 31, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
FDA Approves AstraZeneca Ovarian Cancer Drug 5:12 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca's Lynparza Approved in EU for Ovarian Cancer - Analyst Blog 4:48 p.m. Dec. 19, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – PODD INCY ACAD ALNY 12:15 p.m. Dec. 17, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ZLTQ PBYI CLVS ACHC 12:30 p.m. Dec. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISRG VRTX CLVS VAR 1:45 p.m. Dec. 8, 2014 - InvestorPlace.com
Vargatef cleared in Europe for lung cancer 9:23 a.m. Nov. 28, 2014 - Seeking Alpha
CO-1686 Data Confirmed Efficacy, Take Advantage Of Weakness In Clovis Oncology Shares Ahead Of Rucaparib Outcomes Data 11:41 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly 9:38 a.m. Nov. 19, 2014 - TheStreet.com
Clovis off premarket after report on CO-1686 9:21 a.m. Nov. 19, 2014 - Seeking Alpha
Clovis teams up with Glaxo on combo cancer therapy 7:20 a.m. Nov. 18, 2014 - Seeking Alpha
Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline 4:00 p.m. Nov. 17, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Presents at Credit Suisse 2014 Healthcare Conference (Transcript) 9:10 p.m. Nov. 11, 2014 - Seeking Alpha
10-Q: CLOVIS ONCOLOGY, INC. 1:13 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS 7:33 a.m. Nov. 7, 2014 - benzinga.com
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q3 2014 Results - Earnings Call Transcript 9:40 p.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings after Thursday’s close 5:35 p.m. Nov. 5, 2014 - Seeking Alpha
Clovis Oncology to Present at the 33rd Annual J.P. Morgan Healthcare Conference 6:30 p.m. Jan. 5, 2015 - BusinessWire - BZX
Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib 6:05 p.m. Nov. 19, 2014 - BusinessWire - BZX
Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline 5:00 p.m. Nov. 17, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in TIGER-1 Study 5:28 p.m. Nov. 12, 2014 - BusinessWire - BZX
Clovis Oncology Announces Third Quarter 2014 Operating Results 4:05 p.m. Nov. 6, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Credit Suisse Healthcare Conference 4:11 p.m. Nov. 4, 2014 - BusinessWire - BZX
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer 3:52 p.m. Oct. 23, 2014 - BusinessWire - BZX
Clovis Oncology to Announce Third Quarter 2014 Financial Results and Host Webcast Conference Call on November 6 8:03 a.m. Oct. 22, 2014 - BusinessWire - BZX
Critical Alerts For Yahoo!, Clovis Oncology, Sears Holdings, PetSmart and Endo Health Solutions Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in FGF-aberrant Advanced Breast Cancer 3:01 p.m. Sept. 10, 2014 - BusinessWire - BZX
Clovis Oncology Announces Exercise in Full by Initial Purchasers of Their Option to Purchase an Additional $37.5 Million Aggregate Principal Amount of the Company’s 2.50% Convertible Senior Notes Due 2021 7:02 a.m. Sept. 9, 2014 - BusinessWire - BZX
Clovis Oncology to Present at the 2014 Morgan Stanley Global Healthcare Conference 5:01 a.m. Sept. 8, 2014 - BusinessWire - BZX
Clovis Oncology Announces Pricing of $250 Million of Convertible Senior Notes 7:22 p.m. Sept. 3, 2014 - BusinessWire - BZX
Clovis Oncology to Offer $200 Million of Convertible Senior Notes 3:03 p.m. Sept. 2, 2014 - BusinessWire - BZX
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
Clovis Oncology Announces Second Quarter 2014 Operating Results 3:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 7:10 a.m. July 17, 2014 - PR Newswire - PRF
Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon 4:10 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 6:50 a.m. June 27, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼